This application requests continued support for Northwestern University's membership in the Eastern Cooperative Oncology Group (ECOG). Participation has and will continue to emphasize both group-wide protocols and protocol development using the pilot study format and participation in the disease oriented and data management committees. Northwestern University investigators currently serve on a number of committees. The immediate past principal investigator has served as the Chairman of the Scientific Education Committee. In addition, there is expanded participation in laboratory science protocol development including three flow cytometry protocols and the autologous colon tumor vaccine project. To date, over 130 of an expected 200 paraffin-embedded lymphoma biopsy specimens for the lymphoma ploidy protocol (EST 6486) have been studied. A multidisciplinary inpatient service (32 beds) has become operational at Northwestern Memorial Hospital. A multidisciplinary outpatient service the Kellogg Cancer Care Center, has been established at the Evanston Hospital. Evanston Hospital also has dedicated 30 beds each for medical and surgical oncology. Evanston Hospital functions as a major affiliate of Northwestern University relative to ECOG activities. In addition, Evanston is a CCOP participant. Through the Eastern Cooperative Oncology Group Cancer Control Program Northwestern University has the following affiliates: Veterans Administration Lakeside Medical Center (Dr. Al B. Benson, III); Hematology-Oncology Associates (Dr. John Shaw); Hinsdale Hematology-Oncology Associates, LTD (Dr. Donald Sweet); Northwest Hematology/Oncology (Dr. Elyse Lambaise); Joliet Medical Group (DR. Carol Peterson); Lake Forest Hospital (Dr. Thomas Gynn); Columbus Hospital (Dr. Anita Robinns); and North Suburban Medical Consultants (Dr. Leonard Kosova). New members of the Northwestern University Medical faculty and ECOG participants include Surgical Oncology (Dr. Rosemary Duda), Radiation Oncology) Dr. Krystyna Kiel) and Hematology/Oncology (Drs. Cynthia Radosevich and Martin Tallman). The development of the Section of Hematology/Oncology, the recruitment of additional clinical oncologist in other specialities, and the development of the Protocols Office makes it possible to continue and to increase our participation in ECOG. The Protocol Office under the direction of Dr. Al B. Benson, III and Mrs. Karen Williams has been reconstructed and also now includes research nurses to enhance accrual to ECOG clinical trials and to expand affiliated participation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA017145-17
Application #
3556412
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-06-01
Project End
1994-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
17
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Lubner, Sam; Feng, Yang; Mulcahy, Mary et al. (2018) E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. Oncologist 23:1006-e104
Cohee, Andrea A; Bigatti, Silvia M; Shields, Cleveland G et al. (2018) Quality of Life in Partners of Young and Old Breast Cancer Survivors. Cancer Nurs 41:491-497
Smith, M R; Hong, F; Li, H et al. (2017) Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499. Leukemia 31:517-519
Bhatia, Aarti K; Lee, Ju-Whei; Pinto, Harlan A et al. (2017) Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer 123:4653-4662
Garg, Madhur K; Zhao, Fengmin; Sparano, Joseph A et al. (2017) Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol 35:718-726
Agarwala, Sanjiv S; Lee, Sandra J; Yip, Waiki et al. (2017) Phase III Randomized Study of 4 Weeks of High-Dose Interferon-?-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Gro J Clin Oncol 35:885-892
Sanchez-Martin, Marta; Ambesi-Impiombato, Alberto; Qin, Yue et al. (2017) Synergistic antileukemic therapies in NOTCH1-induced T-ALL. Proc Natl Acad Sci U S A 114:2006-2011
Cohee, Andrea A; Adams, Rebecca N; Fife, Betsy L et al. (2017) Relationship Between Depressive Symptoms and Social Cognitive Processing in Partners of Long-Term Breast Cancer Survivors. Oncol Nurs Forum 44:44-51
Roberts, Kathryn G; Gu, Zhaohui; Payne-Turner, Debbie et al. (2017) High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. J Clin Oncol 35:394-401
Cohee, Andrea A; Adams, Rebecca N; Johns, Shelley A et al. (2017) Long-term fear of recurrence in young breast cancer survivors and partners. Psychooncology 26:22-28

Showing the most recent 10 out of 176 publications